Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Sapporo Clinical Laboratory Inc (9776)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,100.0 +24.0    +2.23%
02/05 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3321100004 
  • Volume: 5,400
  • Bid/Ask: 1,085.0 / 1,100.0
  • Day's Range: 1,082.0 - 1,128.0
Sapporo Clinical Laboratory 1,100.0 +24.0 +2.23%

9776 Balance Sheet

 
Featured here, the Balance Sheet for Sapporo Clinical Laboratory Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 7879 7707 7517 7310
Cash and Short Term Investments 3986 4065 3809 3664
Cash - - - -
Cash & Equivalents 3986 4065 3809 3664
Short Term Investments - - - -
Total Receivables, Net 2953 2944 2882 2924
Accounts Receivables - Trade, Net 2953 2944 2882 2924
Total Inventory 731 555 693 514
Prepaid Expenses - - - -
Other Current Assets, Total 209 143 133 208
Total Assets 16935 16712 16656 16521
Property/Plant/Equipment, Total - Net 8297 8237 8373 8449
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 98 98 87 89
Long Term Investments 517 528 532 525
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 3 2 1 2
Other Assets, Total -1872 -2106 -1910 -2056
Total Current Liabilities 3590 3398 3515 3256
Accounts Payable 2543 2207 2609 2179
Payable/Accrued - - - -
Accrued Expenses 31 254 66 125
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 260 258 258 260
Other Current liabilities, Total 756 679 582 692
Total Liabilities 5835 5689 5869 5641
Total Long Term Debt 1994 2039 2103 2167
Long Term Debt 1498 1531 1565 1598
Capital Lease Obligations 496 508 538 569
Deferred Income Tax 9 11 14 16
Minority Interest 256 263 267 295
Other Liabilities, Total -14 -1689.15 -1728.9 -1825.32
Total Equity 11100 11023 10787 10880
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 983 983 983 983
Additional Paid-In Capital 1015 1015 1015 1015
Retained Earnings (Accumulated Deficit) 9539 9453 9233 9304
Treasury Stock - Common -757 -757 -757 -757
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 320 329 313 335
Total Liabilities & Shareholders' Equity 16935 16712 16656 16521
Total Common Shares Outstanding 3.33 3.33 3.33 3.33
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

9776 Comments

Write your thoughts about Sapporo Clinical Laboratory Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email